WebMaxygen shall own all rights to and interest in any idea, invention (whether patentable or not), discovery or improvement made by or for Maxygen and/or its sublicensees and related to the Selected Strains or Derived Material, and any uses of the Selected Strains or Derived Material obtained through use of the Selected Strains or Derived Material … WebMaxygen Reports First Quarter 2010 Financial Results REDWOOD CITY, Calif., May 6, 2010 — Maxygen, Inc. (Nasdaq: MAXY), a biopharmaceutical company focused on developing improved versions of protein drugs through both internal development and external collaborations and other arrangements, today announced financial and business …

Maxygen - Crunchbase Company Profile & Funding

Web13 jul. 2024 · MAXYGEN, INC.: beurskoers, grafieken, koersen, beursadviezen, financiële gegevens, analyses en real time nieuws van de actie MAXYGEN, INC. US5777761074 Nasdaq shop heart

Collaborative Research and License Agreement - Findlaw

WebTohoku Electric Power Co.Inc. also has decided to participate in the project, ... Astellas will be granted an option to acquire all of Maxygen’s ownership interest in the joint venture at specified exercise prices that will increase each quarter from $53 million to $123 million over the three-year term of the option. Web28 okt. 2010 · Maxygen licensed the technology to Codexis in 2002 as part of the spin-out of Codexis from Maxygen. Codexis is a clean technology company. WebMaxygen further agrees to modify the housing loans provided to you by Maxygen in March 1998 and April 1999 (which loans currently have a total outstanding principal balance of $150,000), to a personal loan for $150,000, with interest calculated semi-annually from February 1, 2001 at 5.59%, and to defer payment of such loan until April 1, 2003 … shop hearing aids online